NSEShareholders meeting7h ago · 25 Sept 2026, 11:52 am
Shareholders meeting
Eris Lifesciences Limited · ERIS
✦ AI SummaryResults
Eris Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026, where the company adopted audited financial statements, appointed a director, ratified cost auditors' remuneration, and re-appointed an independent director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2026
Attachments (1)
📄pdf
Download →
ERIS_25092026115141_Proceedings_of_AGM.pdf
View document text
Date:25September2026
To To
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers ExchangePlaza
DalalStreet BandraKurlaComplex
Mumbai–400001 Bandra(E)
Mumbai–400051
SecurityCode:540596 Symbol:ERIS
SUBJECT:PROCEEDINGSOF20THANNUALGENERALMEETINGOFTHECOMPANYHELDON25THSEPTEMBER
2026
DearSir/Madam,
In terms of Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”), it is hereby informed that the following business items were transacted at the
20thAnnualGeneralMeeting(“AGM”)oftheCompanyheldthroughVideoConferencing(“VC”)on25thSeptember2026:
1. To receive, consider and adopt the Audited Standalone Financial Statements along with Audited Consolidated
FinancialStatementsoftheCompanyfortheFinancialYearendedonMarch31,2026,andthereportsoftheBoardof
DirectorsandtheAuditorsthereon;
2. To appoint a director in place of Mr. Kaushal Kamlesh Shah (DIN: 01229038) who retires by rotation and, being
eligible,offershimselfforre-appointment;
3. ToratifytheremunerationofCostAuditorsfortheFinancialYearendingMarch31,2027;
4. Tore-appointMr.SujeshVasudevan(DIN:08240092)asanIndependentDirectoroftheCompany;
The above businesses were transacted through remote e-voting in accordance with the applicable provisions of law.
The results of the voting on the aforesaid resolutions, as required under Regulation 44(3) of the SEBI (Listing
ObligationsandDisclosureRequirements)Regulations,2015,willbedisclosedtotheStockExchangesseparately.
TheAnnualGeneralMeetingcommencedat11:00A.M.andconcludedat11:30A.M.
Kindlytakenoteoftheabove.
ForErisLifesciencesLimited
MilindTalegaonkar
CompanySecretary&ComplianceOfficer
MembershipNo:A26493